Long-term consequences of Hodgkin lymphoma therapy on T-cell lymphopoiesis - 05/03/15
![](/templates/common/images/mail.png)
This study was supported by an institutional grant from the Angers University Hospital and by a funding from the association “Les sapins de l'espoir.” |
|
Disclosure of potential conflict of interest: J. Rakotonjanahary and E. Berardi are employed by CHU Angers France. E. Garo has received research support from the University of Angers. S. Blanchard has received research support from the Angers University Hospital and Les Sapins de L'espoir. A. Fischer has received research support in the form of a senior European Research Council grant PIDIMMUN (no. 249816). A. Tanguy-Schmidt and P. Jeannin have received research support from Les Sapins de L'espoir. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 135 - N° 3
P. 818 - mars 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?